TRU (TRU)

$12.9B
Market Cap
28.7
P/E Ratio
1.70
Beta
0.76%
Dividend Yield
Piotroski 8/9Altman Z 2.3 Gray ZoneBeneish M -2.66 CleanROIC−WACC -5.1%

Quantitative Summary

Deterministic

Strong operational fundamentals (Piotroski 8/9) with Altman Z of 2.3.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The underlying economics exhibit a robust balance sheet profile characterized by a Piotroski F-Score of 8/9 and a negative Beneish M-Score of -2.66, signaling strong fundamental quality with minimal earnings manipulation risk. The DuPont decomposition reveals that the 10% return on equity is primarily driven by operational leverage rather than asset efficiency; while net margins sit at an attractive 10%, this is offset by a modest 0.41x asset turnover rate and elevated financial leverage of 2.44x, which dilutes free cash flow generation despite the high gross margin of 59.1%. Although revenue growth remains steady at 9.4% year-over-year, the return on invested capital stands at only 7%, indicating that the current equity multiplier is necessary to achieve the reported ROE but may constrain long-term organic expansion potential relative to industry peers with higher asset efficiency.

Valuation metrics suggest a significant premium over intrinsic value, as the current price-to-earnings ratio of 28.7x exceeds typical multiples for firms with similar growth trajectories and margin profiles. While the DCF model implies a fair value of $68, suggesting substantial upside if market assumptions regarding future cash flows hold true, the high multiple indicates that investors are already pricing in aggressive long-term growth expectations not fully reflected in current fundamentals. The divergence between the 9% revenue growth rate and the steep valuation compression risk highlights a potential mean reversion scenario where earnings power must accelerate to justify existing share prices without further leverage or margin expansion.

Insider activity presents a notable counterweight to the positive fundamental scores, with $1,038,464 in net selling over the past 90 days. This consistent outflow by management could signal concerns about near-term valuation levels or capital allocation priorities that differ from retail sentiment, introducing an element of uncertainty regarding future insider confidence despite the company's strong historical financial integrity scores.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →10.1%12.1%14.1%
2%$83$61$46
3%$95$68$50
4%$111$77$56

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=12.1%, terminal growth 3%. Fair value $68 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

8/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
2.3
Altman Z-Score
Grey Zone — between 1.8 and 3.0 thresholds. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.66
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

59.1%
Gross Margin
10.0%
Net Margin
7.0%
ROIC
12.1%
WACC
ROIC − WACC Spread: -5.1%— Negative spread.
+9.4%
Revenue Growth (YoY)
+60.1%
Earnings Growth (YoY)
661.6M
Free Cash Flow
14%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

10.0%
Net Profit Margin
NI ÷ Revenue
×
0.41x
Asset Turnover
Revenue ÷ Assets
×
2.44x
Equity Multiplier
Assets ÷ Equity
=
10.0%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

1.44x
Debt / Equity
1.75x
Current Ratio
3.7x
Interest Coverage
2.8x
Net Debt / EBITDA
3.91%
FCF Yield
1.5B
EBITDA

Insider Activity (Last 90 Days)

Net Insider Flow
-$1M
Net Selling
0
Buy Transactions
7
Sale Transactions
2026-03-06RUSSELL HEATHER JSold 4/8 qtrsSale$314,664
2026-03-03WILLIAMS JENNIFER ASold 4/8 qtrsSale$134,320
2026-03-02CHAOUKI STEVEN MSold 8/8 qtrsSale$383,200
2026-03-02SKINNER TODD C.Sold 4/8 qtrsSale$38,320
2026-02-27CELLO TODD M.Sold 1/8 qtrsGrant19,987 shares

Open-market buys vs sells by company insiders. Source: yfinance.

Earnings Surprise History

Q4
✓ Beat
Est: $0.98
Act: $1.05
+7.3%
Q3
✓ Beat
Est: $0.99
Act: $1.08
+9.0%
Q2
✓ Beat
Est: $1.04
Act: $1.10
+5.4%
Q1
✓ Beat
Est: $1.03
Act: $1.07
+4.3%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

11.4
Forward P/E
PEG Ratio
2.89
Price/Book
3M
Avg Volume
$99.39
52W High
$65.23
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$832M
Tracked Passive Exposure
8
ETFs Holding TRU
0.19%
Avg Weight in ETFs
$428B
Total ETF AUM

When investors buy or sell ETFs like MDYG or SPMD, the fund manager is mechanically forced to buy or sell TRU shares regardless of TRU's individual fundamentals. We estimate $832M of passive capital is structurally linked to TRU through 8 tracked ETFs. Passive flows have a limited but growing influence on TRU's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in TRU to visualize passive redemption contagion across ETFs and collateral stocks.

TRU Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
TRUEpicenterVBETFVXFETFVBRETFFLEXMed RiskFTILow RiskTWLOLow RiskCWLow RiskNVTLow Risk
TRU Price Drop (%)0

If TRU (TRU) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies FLEX LTD (FLEX) as the most exposed collateral stock, sharing 2 ETFs with TRU. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 15 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

TRU Ownership Dynamics

Ticker
TRU

Float lock-up computed from 19 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

TRU Capital Efficiency

How efficiently does TRU convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$662M
EBITDA
$1.5B
FCF Conversion
46%
Reinvestment Rate
54%
46% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
7.0%
ROIC − WACC Spread
-5.1%

TRU converts 46% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The 54% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-5.1%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-06116,872$68.24$8.0M
2026-04-27386$72.61$28,027.46
2026-04-241,374$73.08$100,411.92
2026-04-2013$78.25$1,017.25
2026-04-0926$71.20$1,851.2
2026-03-276,490$68.24$442,877.6
2026-03-262,990$67.72$202,482.8
2026-03-2561,170$68.62$4.2M
2026-03-232,885$70.55$203,536.75
2026-03-1912$73.05$876.6
2026-03-1871,336$73.66$5.3M
2026-03-1713,268$70.71$938,180.28
2026-03-10529$76.05$40,230.45
2026-03-031,114$78.31$87,237.34
2026-02-24262$71.23$18,662.26
2026-02-23302$76.20$23,012.4
2026-02-172,629$73.92$194,335.68
2026-02-0527,617$69.50$1.9M
2026-02-032$77.21$154.42
2026-01-20200$86.22$17,244
2026-01-1544,795$85.50$3.8M
2026-01-0841$83.50$3,423.5
2026-01-063,502$86.95$304,498.9
2025-12-2217,851$87.09$1.6M
2025-12-122,933$85.76$251,534.08
2025-12-1147$84.23$3,958.81
2025-12-094,146$82.01$340,013.46
2025-12-0518,474$84.19$1.6M
2025-11-261,762$85.10$149,946.2
2025-11-2083$81.88$6,796.04

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare TRU to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.